av/cadila-healthcare--big.svg

COM:ZYDUSLIFE

Zydus Lifesciences Ltd.

  • Stock

Last Close

944.05

22/11 10:00

Market Cap

1.17T

Beta: -

Volume Today

295.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
9.42B
-
14.46B
53.42%
21.24B
46.92%
16.12B
24.10%
23.12B
43.43%
23.82B
3.03%
14.95B
37.22%
22.85B
52.79%
52.32B
129.00%
25.83B
50.64%
48.38B
87.33%
depreciation and amortization
2.01B
-
2.87B
42.79%
3.02B
5.19%
3.75B
24.09%
5.41B
44.13%
5.99B
10.75%
6.96B
16.35%
7.25B
4.06%
7.36B
1.56%
7.23B
1.82%
7.64B
5.73%
deferred income tax
stock based compensation
change in working capital
-359M
-
-3.77B
950.14%
2.66B
170.45%
-3.73B
240.36%
-13.84B
271.22%
6.38B
146.09%
1.29B
79.71%
1.87B
44.36%
-3.52B
288.17%
-2.36B
32.92%
-8.71B
269.42%
accounts receivables
-6.43B
-
5.64B
187.68%
4.31B
23.47%
-1.82B
142.13%
-8.48B
366.98%
-7.47B
11.94%
inventory
-1.54B
-
-1.68B
9.22%
845M
150.24%
-4.67B
652.19%
-5.92B
26.96%
-1.00B
83.05%
-1.01B
0.60%
-4.80B
374.95%
-5.25B
9.55%
4.41B
183.86%
-20M
100.45%
accounts payables
-2.26B
-
564M
124.97%
1.71B
203.01%
-1.20B
170.39%
-1.71B
41.98%
-448M
73.77%
other working capital
1.18B
-
-2.09B
276.80%
1.81B
186.73%
938M
48.21%
-7.92B
943.82%
16.07B
303.02%
-3.90B
124.25%
643M
116.50%
4.76B
640.28%
3.43B
27.98%
-771M
122.49%
other non cash items
-2.21B
-
-3.62B
64.26%
-6.98B
92.63%
-2.65B
62.08%
-5.49B
107.60%
-7.36B
34.03%
1.84B
125.01%
966M
47.53%
-35.13B
3,736.44%
-3.81B
89.16%
-370M
90.28%
net cash provided by operating activities
8.87B
-
9.94B
12.02%
19.94B
100.66%
13.49B
32.32%
9.19B
31.88%
28.82B
213.53%
25.05B
13.08%
32.93B
31.44%
21.04B
36.10%
26.89B
27.79%
32.28B
20.05%
investments in property plant and equipment
-4.68B
-
-5.12B
9.44%
-9.72B
89.66%
-29.78B
206.45%
-10.49B
64.77%
-10.57B
0.77%
-9.04B
14.50%
-8.54B
5.54%
-12.03B
40.82%
-10.31B
14.28%
-9.07B
12.06%
acquisitions net
-48.68B
-
1.56B
103.22%
1.03B
33.87%
2.07B
100.10%
1.15B
44.66%
-7.20B
728.36%
purchases of investments
-10M
-
-115M
1,050%
-1M
99.13%
-48.81B
-
-1.85B
96.21%
-400M
78.38%
-7.84B
1,859.25%
-2.61B
66.75%
-4.64B
78.24%
sales maturities of investments
5M
-
53M
-
116M
118.87%
1.35B
1,067.24%
285M
78.95%
101M
64.56%
751M
643.56%
23.36B
3,009.99%
4.63B
80.19%
other investing activites
470M
-
587M
24.89%
680M
15.84%
625M
8.09%
640M
2.40%
49.32B
7,606.72%
-1.08B
102.19%
579M
153.51%
28.59B
4,836.96%
125M
99.56%
9M
92.80%
net cash used for investing activites
-4.22B
-
-4.65B
10.07%
-9.04B
94.51%
-29.10B
221.97%
-9.74B
66.54%
-57.39B
489.37%
-10.12B
82.36%
-7.22B
28.63%
11.54B
259.78%
11.71B
1.46%
-14.75B
225.96%
debt repayment
-4.21B
-
-9.00B
113.78%
-4.68B
47.94%
-6.45B
37.64%
-2.65B
58.96%
-1.70B
35.60%
-7.86B
360.97%
-25.68B
226.96%
-14.21B
44.68%
-9.96B
29.90%
-3.93B
60.55%
common stock issued
9.87B
-
18.59B
-
common stock repurchased
-8.34B
-
-8.63B
-
-7.25B
16.01%
dividends paid
-1.53B
-
-1.84B
19.96%
-5.79B
214.79%
-3.27B
43.50%
-3.58B
-
-7.17B
100%
-15M
99.79%
-3.72B
24,713.33%
-2.67B
28.24%
-6.21B
132.50%
other financing activites
455M
-
7.33B
1,510.11%
946M
87.09%
32.88B
3,375.26%
3.16B
90.39%
24.13B
663.46%
4.08B
83.10%
-1.32B
132.36%
9.25B
800.53%
-41.33B
546.99%
-3.83B
90.73%
net cash used provided by financing activities
-5.29B
-
-3.51B
33.59%
-9.53B
171.35%
23.16B
343.08%
515M
97.78%
18.85B
3,559.42%
-10.94B
158.06%
-25.49B
132.95%
-8.68B
65.93%
-44.00B
406.78%
-18.10B
58.86%
effect of forex changes on cash
6M
-
1.61B
-
79M
95.09%
-42M
153.16%
86M
304.76%
66M
23.26%
-231M
450%
net change in cash
-639M
-
1.78B
378.25%
1.37B
22.83%
7.56B
450.73%
-29M
100.38%
-7.11B
24,400%
3.99B
156.14%
-905M
122.69%
23.73B
2,721.99%
-5.34B
122.50%
-748M
85.99%
cash at beginning of period
6.76B
-
6.13B
9.45%
7.90B
29.02%
8.37B
5.90%
15.93B
90.27%
15.90B
0.18%
7.79B
51.01%
11.78B
51.22%
10.87B
7.68%
11.07B
1.81%
4.88B
55.93%
cash at end of period
6.13B
-
7.90B
29.02%
9.28B
17.36%
15.93B
71.69%
15.90B
0.18%
8.79B
44.69%
11.78B
33.95%
10.87B
7.68%
34.60B
218.26%
5.73B
83.44%
4.13B
27.94%
operating cash flow
8.87B
-
9.94B
12.02%
19.94B
100.66%
13.49B
32.32%
9.19B
31.88%
28.82B
213.53%
25.05B
13.08%
32.93B
31.44%
21.04B
36.10%
26.89B
27.79%
32.28B
20.05%
capital expenditure
-4.68B
-
-5.12B
9.44%
-9.72B
89.66%
-29.78B
206.45%
-10.49B
64.77%
-10.57B
0.77%
-9.04B
14.50%
-8.54B
5.54%
-12.03B
40.82%
-10.31B
14.28%
-9.07B
12.06%
free cash flow
4.19B
-
4.81B
14.90%
10.22B
112.39%
-16.29B
259.35%
-1.30B
92.02%
18.25B
1,503.77%
16.01B
12.25%
24.39B
52.31%
9.02B
63.04%
16.58B
83.90%
23.21B
40.01%

All numbers in (except ratios and percentages)